Strasbourg, France - Further details of the results of the Carvedilol or Metoprolol European Trial (COMET), comparing the beta blockers carvedilol and metoprolol in heart failure, were presented at ...

The disparity in the results between the Metoprolol in Dilated Cardiomyopathy Trial and MERIT-HF raised the possibility that only extended- release metoprolol succinate is effective in treating heart ...

Many providers confuse metoprolol tartrate (Lopressor) and metoprolol succinate (Toprol XL). Here is an easy way to keep them straight: Tartrate with a T is Twice a day or more, and succinate with an ...

Growing Advancement in Pharmaceutical Industry is Propelling the Growth of the Metoprolol Tartrate Market HYDERABAD, TELANGANA, INDIA, October 20, 2022 / / -- size is estimated to reach $868.3 million ...

Aficamten, a cardiac myosin inhibitor, outperformed metoprolol in treating symptomatic obstructive hypertrophic cardiomyopathy in the MAPLE-HCM trial. The trial demonstrated aficamten's superior ...

AstraZeneca plcAZN announced that it has signed an agreement with Recordati S.p.A, granting commercial rights to Seloken/Seloken ZOK (metoprolol tartrate and metoprolol succinate respectively) and ...

AstraZeneca is selling European rights to its metolprolol beta blocker Seloken ® /Seloken ® ZOK (metoprolol tartrate/metoprolol succinate) and Logimax ® fixed-dose combination therapy (metoprolol ...